177 related articles for article (PubMed ID: 32056843)
1. A novel human monoclonal antibody potently neutralizes human adenovirus serotype 7 by primarily targeting the adenovirus hexon protein.
Lu J; Wang R; Huang Y; Yu Y; Zhou X; Huang P; Yang Z
Virology; 2020 Apr; 543():20-26. PubMed ID: 32056843
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Critical and Conformational Neutralizing Epitope in Human Adenovirus Type 4 Hexon.
Tian X; Qiu H; Zhou Z; Wang S; Fan Y; Li X; Chu R; Li H; Zhou R; Wang H
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093098
[TBL] [Abstract][Full Text] [Related]
3. Epitope mapping and characterization of a neutralizing monoclonal antibody against human adenovirus type 3.
Tian X; Li C; Xue C; Li X; Zhou Z; Zhou R
Virus Res; 2013 Nov; 177(2):189-93. PubMed ID: 24018287
[TBL] [Abstract][Full Text] [Related]
4. Generation of neutralizing monoclonal antibodies against a conformational epitope of human adenovirus type 7 (HAdv-7) incorporated in capsid encoded in a HAdv-3-based vector.
Liu M; Tian X; Li X; Zhou Z; Li C; Zhou R
PLoS One; 2014; 9(7):e103058. PubMed ID: 25054273
[TBL] [Abstract][Full Text] [Related]
5. Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions.
Qiu H; Li X; Tian X; Zhou Z; Xing K; Li H; Tang N; Liu W; Bai P; Zhou R
J Virol; 2012 Aug; 86(15):7964-75. PubMed ID: 22623776
[TBL] [Abstract][Full Text] [Related]
6. Mapping the epitope of neutralizing monoclonal antibodies against human adenovirus type 3.
Tian X; Liu M; Su X; Jiang Z; Ma Q; Liao X; Li X; Zhou Z; Li C; Zhou R
Virus Res; 2015 Oct; 208():66-72. PubMed ID: 26071383
[TBL] [Abstract][Full Text] [Related]
7. A Murine Monoclonal Antibody With Potent Neutralization Ability Against Human Adenovirus 7.
Wang R; Lu J; Zhou Q; Chen L; Huang Y; Yu Y; Yang Z
Front Cell Infect Microbiol; 2019; 9():417. PubMed ID: 31867291
[TBL] [Abstract][Full Text] [Related]
8. Epitope mapping and cross-reactivity analysis of the monoclonal antibodies against hexon protein of human adenovirus type 3.
Qiu H; Zhou Z; Feng K; Tian X; Li X; Li H; Xing K; Chen J; Li C; Zhou R
Virus Res; 2009 Dec; 146(1-2):58-65. PubMed ID: 19732803
[TBL] [Abstract][Full Text] [Related]
9. Worldwide increased prevalence of human adenovirus type 3 (HAdV-3) respiratory infections is well correlated with heterogeneous hypervariable regions (HVRs) of hexon.
Haque E; Banik U; Monowar T; Anthony L; Adhikary AK
PLoS One; 2018; 13(3):e0194516. PubMed ID: 29590206
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing epitopes mapping of human adenovirus type 14 hexon.
Ma Q; Tian X; Jiang Z; Huang J; Liu Q; Lu X; Luo Q; Zhou R
Vaccine; 2015 Nov; 33(48):6659-65. PubMed ID: 26546264
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis reveals four major hexon variants of human adenovirus type-3 (HAdV-3) as the potential strains for development of vaccine and siRNA-based therapeutics against HAdV-3 respiratory infections.
Panda S; Banik U; Adhikary AK
Infect Genet Evol; 2020 Nov; 85():104439. PubMed ID: 32585339
[TBL] [Abstract][Full Text] [Related]
12. Development of two antigen-binding fragments to a conserved linear epitope of human adenovirus and their application in immunofluorescence.
Liu Z; Tian X; Liu W; Xian Y; Chen W; Chen H; Zhou R
PLoS One; 2019; 14(6):e0219091. PubMed ID: 31242267
[TBL] [Abstract][Full Text] [Related]
13. Development of monoclonal antibodies targeting the conserved fragment of hexon protein to detect different serotypes of human adenovirus.
Wu L; Lin Y; Yin J; Yang C; Jiang Y; Zhai L; Wang Y; Zhu L; Wu Q; Zhang B; Wan C; Zhao W; Yang Y; Shen C; Xiao W
Microbiol Spectr; 2024 Apr; 12(4):e0181623. PubMed ID: 38385650
[TBL] [Abstract][Full Text] [Related]
14. Identification of adenovirus neutralizing antigens using capsid chimeric viruses.
Liu T; Fan Y; Li X; Gu S; Zhou Z; Xu D; Qiu S; Li C; Zhou R; Tian X
Virus Res; 2018 Sep; 256():100-106. PubMed ID: 30096411
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection.
Bradley RR; Lynch DM; Iampietro MJ; Borducchi EN; Barouch DH
J Virol; 2012 Jan; 86(1):625-9. PubMed ID: 22072776
[TBL] [Abstract][Full Text] [Related]
16. A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55.
Liu T; Zhou Z; Tian X; Liu W; Xu D; Fan Y; Liao J; Gu S; Li X; Zhou R
Vaccine; 2018 Apr; 36(16):2199-2206. PubMed ID: 29548605
[TBL] [Abstract][Full Text] [Related]
17. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
[TBL] [Abstract][Full Text] [Related]
18. Recombinant influenza virus carrying human adenovirus epitopes elicits protective immunity in mice.
Yang P; Li T; Liu N; Gu H; Han L; Zhang P; Li Z; Wang Z; Zhang S; Wang X
Antiviral Res; 2015 Sep; 121():145-51. PubMed ID: 26112646
[TBL] [Abstract][Full Text] [Related]
19. Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection.
Tischer S; Geyeregger R; Kwoczek J; Heim A; Figueiredo C; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
J Transl Med; 2016 Oct; 14(1):286. PubMed ID: 27717382
[TBL] [Abstract][Full Text] [Related]
20. Detection of antibodies against adenovirus protein IX, fiber, and hexon in human sera by immunoblot assay.
Bauer U; Flunker G; Bruss K; Kallwellis K; Liebermann H; Luettich T; Motz M; Seidel W
J Clin Microbiol; 2005 Sep; 43(9):4426-33. PubMed ID: 16145087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
